News for Healthier Living
Genetic Testing Reduces Risks From Chemotherapy for Gastrointestinal Cancer Patients
For some patients with gastrointestinal (GI) cancers like colorectal and pancreatic cancer, chemotherapy can cause severe, sometimes life-threatening side effects in those who carry certain genetic variants that can impact how their bodies process the drugs used to treat their disease. Testing for variants in two genes before starting chemotherapy can significantly improve patient safety by providing physicians with information to help tailor doses, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Those who were found to have one of the genes had half as many side effects in half, as compared to patients with the genes that were given standard doses without testing, according to results published today in JCO Precision Oncology.
August 7, 2025
August 21 2025August 20 2025 - The Tiniest Touch, The Greatest Hope
- International Collaboration on Nursing and Midwifery in the Caribbean Deemed a Success, According to New Study
- How the Indirect Effects of Nurture NJ Bolster Maternal Health Initiatives
- Unique Active Memory Computer Purpose-built for AI Science Applications
- A New, Non-Addictive Painkiller is on the Horizon
- AABB Updates Transfusion Standards After Another Massive Carson Study
- Pedestrian Safety Tips
- Parkinson's Disease Risk Increases with Metabolic Syndrome
- FDA Approves Sublingual, Nonopioid Daily Treatment for Fibromyalgia
- AAP Issues New Vaccine Guidelines That Differ From U.S. Government Advice
- FDA Approves Wegovy to Treat Serious Liver Disease
- Walmart Recalls Frozen Shrimp Over FDA Warning About Radiation Risk
- New Strategy for Small Cell Lung Cancer Treatment Emerges from Dana-Farber Science
- New Cleveland Clinic Research Identifies Link Between Gut Microbes and an Elevated Risk for Abdominal Aortic Aneurysms
- Weather Disasters Increase Risk for U.S. Drug Supply Chain Disruption, New ACS Research Shows
- Cancer-Associated Nerve Injury Leads to Chronic Inflammation and Immunotherapy Resistance
- 'Philadelphia Consensus' Sets New Standard for Treating Devastating Xylazine-Related Injuries
- Researchers Map Epigenomic Landscapes of Fat Tissue Cells, Revealing How They Shape Obesity Risk
- Bullied Teens Less Likely to Be Depressed if They Feel Connected at School, Study Shows
- Seniors Neglecting Steps To Protect Heart Health, Study Says
- Pesticide Linked To Impaired Brain Development Among Kids
- Sensitive People More Vulnerable To Mood Disorders
- Do No Harm: Rethink Treating Diabetes, Hypertension in Frail Older Adults
- Tight Blood Pressure Control Both Healthy And Cost-Effective, Projections Say
- Thin Endometrium Shouldn't Lower Odds Of Successful IVF Pregnancy, Study Says
- COVID Can Prematurely Age Blood Vessels
- Plant-Based Diets Can Reduce the Risk of Multimorbidity
- Building a Better Database to Detect Designer Drugs
- New Graphene Technology Matures Brain Organoids Faster, May Unlock Neurodegenerative Insights
August 19 2025August 18 2025August 17 2025August 16 2025August 15 2025August 14 2025August 13 2025August 12 2025August 11 2025August 10 2025August 9 2025August 8 2025August 7 2025
|
|
|
|
|